Close

Jefferies Comments on Amarin (AMRN) Following Management Meetings; Bullish on AMR101, Sees No FDA Regulation Risk Sep 23, 2011 01:13PM
Jefferies Comments on Amarin (AMRN) Following European Society of Cardiology Meeting on AMR101 Sep 1, 2011 08:36AM
Jefferies Comments on Amarin (AMRN), Remains One of the Top Picks in Biotech Aug 30, 2011 09:15AM
Jefferies Comments on Final Rejection Letter of Amarin's (AMRN) MARINE Patent, Reaffirms Buy Rating Aug 19, 2011 10:31AM
Jefferies Sees Upside in Shares of Amarin Corp. (AMRN), Looks for Patents to Provide Protection Through 2025 and 2030 Jun 27, 2011 10:41AM


May 31, 2011 09:14AM Jefferies Provides Highlight From Recent Meetings With Amarin Corp. (AMRN), Maintains $25 Price Target
May 16, 2011 08:29AM Jefferies Maintains a 'Buy' on Amarin (AMRN); Raising Price Target After Discussion With FDA On AMR101 Patents
May 3, 2011 08:28AM Jefferies Says AHA New Triglyceride Clinical CV Guidelines Positive for Amarin (AMRN)
Apr 19, 2011 07:55AM Jefferies Raises Price Target on Amarin Corp. (AMRN), Raises Valuation on Impressive ANCHOR Topline Data
Feb 2, 2011 08:05AM Jefferies Starts Amarin Corporation (AMRN) at Buy
Jan 5, 2011 06:00PM Amarin Corp. (AMRN) Intends ADS Offering
Jan 28, 2010 02:17PM Unusual 11 Mid-Day Movers 1/28: NFLX, PFBC, NLST, EK Higher; KSP, AMRN, CNLG, TTEK Lower